These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8145917

  • 1. Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria.
    Ogilvie I, Pourfarzam M, Jackson S, Stockdale C, Bartlett K, Turnbull DM.
    Neurology; 1994 Mar; 44(3 Pt 1):467-73. PubMed ID: 8145917
    [Abstract] [Full Text] [Related]

  • 2. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S, Matsushita T, Furuyama H, Tajima G, Shigematsu Y, Imai T, Shimohama S.
    Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
    [Abstract] [Full Text] [Related]

  • 3. Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome.
    Treem WR, Witzleben CA, Piccoli DA, Stanley CA, Hale DE, Coates PM, Watkins JB.
    Hepatology; 1986 Apr; 6(6):1270-8. PubMed ID: 3793003
    [Abstract] [Full Text] [Related]

  • 4. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.
    Aoyama T, Uchida Y, Kelley RI, Marble M, Hofman K, Tonsgard JH, Rhead WJ, Hashimoto T.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1369-72. PubMed ID: 8466512
    [Abstract] [Full Text] [Related]

  • 5. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
    Cox KB, Hamm DA, Millington DS, Matern D, Vockley J, Rinaldo P, Pinkert CA, Rhead WJ, Lindsey JR, Wood PA.
    Hum Mol Genet; 2001 Sep 15; 10(19):2069-77. PubMed ID: 11590124
    [Abstract] [Full Text] [Related]

  • 6. Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.
    Vianey-Saban C, Divry P, Brivet M, Nada M, Zabot MT, Mathieu M, Roe C.
    Clin Chim Acta; 1998 Jan 12; 269(1):43-62. PubMed ID: 9498103
    [Abstract] [Full Text] [Related]

  • 7. The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies.
    Gregersen N.
    Scand J Clin Lab Invest Suppl; 1985 Jan 12; 174():1-60. PubMed ID: 3892650
    [Abstract] [Full Text] [Related]

  • 8. Complementation analysis of fatty acid oxidation disorders.
    Moon A, Rhead WJ.
    J Clin Invest; 1987 Jan 12; 79(1):59-64. PubMed ID: 3793932
    [Abstract] [Full Text] [Related]

  • 9. Immunochemical characterization of variant long-chain acyl-CoA dehydrogenase in cultured fibroblasts from nine patients with long-chain acyl-CoA dehydrogenase deficiency.
    Indo Y, Coates PM, Hale DE, Tanaka K.
    Pediatr Res; 1991 Sep 12; 30(3):211-5. PubMed ID: 1945557
    [Abstract] [Full Text] [Related]

  • 10. Very long-chain acyl-CoA dehydrogenase deficiency presenting as acute hypercapnic respiratory failure.
    Tong MK, Lam CS, Mak TW, Fu MY, Ng SH, Wanders RJ, Tang NL.
    Eur Respir J; 2006 Aug 12; 28(2):447-50. PubMed ID: 16880373
    [Abstract] [Full Text] [Related]

  • 11. Immunochemical characterization of variant medium-chain acyl-CoA dehydrogenase in fibroblasts from patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Coates PM, Indo Y, Young D, Hale DE, Tanaka K.
    Pediatr Res; 1992 Jan 12; 31(1):34-8. PubMed ID: 1594327
    [Abstract] [Full Text] [Related]

  • 12. Combined enzyme defect of mitochondrial fatty acid oxidation.
    Jackson S, Kler RS, Bartlett K, Briggs H, Bindoff LA, Pourfarzam M, Gardner-Medwin D, Turnbull DM.
    J Clin Invest; 1992 Oct 12; 90(4):1219-25. PubMed ID: 1401059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered Energetics of Exercise Explain Risk of Rhabdomyolysis in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency.
    Diekman EF, Visser G, Schmitz JP, Nievelstein RA, de Sain-van der Velden M, Wardrop M, Van der Pol WL, Houten SM, van Riel NA, Takken T, Jeneson JA.
    PLoS One; 2016 Oct 12; 11(2):e0147818. PubMed ID: 26881790
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of dantrolene sodium in Very Long Chain Acyl-CoA Dehydrogenase Deficiency.
    Voermans NC, Poels PJ, Kluijtmans LA, van Engelen BG.
    Neuromuscul Disord; 2005 Dec 12; 15(12):844-6. PubMed ID: 16288870
    [Abstract] [Full Text] [Related]

  • 17. Rhabdomyolysis caused by an inherited metabolic disease: very long-chain acyl-CoA dehydrogenase deficiency.
    Voermans NC, van Engelen BG, Kluijtmans LA, Stikkelbroeck NM, Hermus AR.
    Am J Med; 2006 Feb 12; 119(2):176-9. PubMed ID: 16443431
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Catalytic defect of medium-chain acyl-coenzyme A dehydrogenase deficiency. Lack of both cofactor responsiveness and biochemical heterogeneity in eight patients.
    Amendt BA, Rhead WJ.
    J Clin Invest; 1985 Sep 12; 76(3):963-9. PubMed ID: 3840178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.